Skip to content

Pharmacy

AmerisourceBergen becomes Cencora

AmerisourceBergen becomes Cencora

Cencora, Inc. today announced the completion of its name and stock ticker change from AmerisourceBergen Corporation, marking the latest stage of the company’s evolution as a leader in global pharmaceutical services.

NABP launches pulse interoperable partner program

NABP launches pulse interoperable partner program

The National Association of Boards of Pharmacy (NABP) today announced the launch of the Pulse Interoperable Partner program, a new initiative that will provide a framework for solution providers to integrate directly with Pulse by NABP and help accelerate interoperability in the drug supply chain.

CVS Health launches Cordavis

CVS Health launches Cordavis

CVS Health has launched Cordavis, a wholly owned subsidiary that will work directly with manufacturers to commercialize and/or co-produce biosimilar products (an FDA approved biologic medication that is highly similar to, and has no clinically meaningful differences from, a biologic medicine already

Mark Cuban Cost Plus Drug Co. and Drexi partner

Mark Cuban Cost Plus Drug Co. and Drexi partner

Drexi, a cutting-edge pharmacy benefit manager (PBM), and Mark Cuban Cost Plus Drug Co., PBC (Cost Plus Drugs), have teamed up to address one of the most pressing challenges in healthcare today: providing better access to the right drugs at affordable prices.